Form 8-K - Current report:
SEC Accession No. 0001116502-03-001119
Filing Date
2003-06-20
Accepted
2003-06-19 19:47:32
Documents
5
Period of Report
2003-06-19
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8kbplp.htm 8-K 27541
3 BIOSPECIFICS SENIOR SECURED NOTE seniorsecurednote1020.txt EX-10.20 30047
4 SECURITIES PURCHASE AGREEMENT purchaseagreement1021.txt EX-10.21 82219
5 INVESTOR RIGHTS AGREEMENT rightsagreement1022.txt EX-10.22 38633
6 CURRENT REPORT biospecifics-8k.pdf 8-K 446784
  Complete submission text file 0001116502-03-001119.txt   627317
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19879 | Film No.: 03750821
SIC: 2834 Pharmaceutical Preparations